EMA Authorised: Loargys (Pegzilarginase) — Immedica Pharma AB

View source ↗

Summary

The EMA has authorized Loargys (pegzilarginase) by Immedica Pharma AB for hyperargininemia, with orphan medicine designation indicating a rare-disease indicatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperargininemia

Drugs mentioned

• LOARGYS (PEGZILARGINASE-NBLN)

Snippet

Status: Authorised. Therapeutic area: Hyperargininemia. MAH: Immedica Pharma AB. Decision date: 17/11/2025. Orphan medicine